@FiercePharma: Dendreon cites CMS review for sales trouble, but The Street's take is more plausible: Cash-flow-conscious oncologists. Article | Follow @FiercePharma
> FDA officials say regulatory approval for biosimilars can't depend on a "one-size-fits-all" process, but on an approach specific to each product. Report
> Valeant Pharmaceutical profits skyrocketed by 66% on strong sales in Europe, Latin America, Canada and Australia. Article
> Generics maker Par Pharmaceutical beat analyst estimates for second-quarter profits, but revenue dropped by 12% to $224.2 million. News
> Mexico's Instituto Bioclon won the FDA nod for Anascorp, the first-ever treatment designed specifically for scorpion stings. FDA release | News
> As Medco Health Solutions stock drops on worries that U.S. antitrust regulators will block the Express Scripts buyout, arbitragers are jumping into the gap. Item
Biotech News
@FierceBiotech: Celgene tackles anemia in $242M development pact with Acceleron. Piece | Follow @FierceBiotech
@JohnCFierce: Bloomberg covers the provenge disaster. Doctors confused about coverage? Really? I'm not buying it. Item | Follow @JohnCFierce
@MaureenFierce: FDA's Woodcock on biosimilars: No "one size fits all" approach. Report | Follow @MaureenFierce
> Tiny French biotech touts success of new hep C vaccine. More
> FDA sketches a complex instruction manual for biosimilars. Story
> Pfizer axes $195M Biotica pact, hands back rights to MS, lupus drugs. Item
> Tiny trial suffices for FDA approval of scorpion sting antidote. Report
Manufacturing News
> Musty odor exudes from J&J board report exonerating execs. More
> Pharma slices cargo theft in H1 2011. Report
> FDA foreign force multiplier demo'd in API inspections. Article
> Catalent catches the cold chain wave. News
> Developed world feeling sting of fake drugs. Story
Vaccines News
> FDA delays decision on Pfizer's Prevnar 13. News
> Inviragen forms dengue partnership with IVI. More
> Start-up Vaxxas lands $16.46M for vaccine nanopatch. Article
> Merck, Serum Institute sign pneumococcal vaccine deal. Report
And Finally... SSRI antidepressants may carry more side effects than tricyclics in people over 65. Story